COMPASS: intravenous ateplase and the efficacy of aspiration vs. stent retriever thrombectomy episode artwork

EPISODE · Nov 17, 2021 · 16 MIN

COMPASS: intravenous ateplase and the efficacy of aspiration vs. stent retriever thrombectomy

from JNIS Podcast · host BMJ Group

In this podcast, we discuss the COMPASS: a trial of aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion, comparing patients with and without prior intravenous (IV) alteplase administration. JNIS Editor-in-Chief, Felipe C. Albuquerque, interviews Maxim Mokin, from the Department of Neurosurgery and Brain Repair, University of South Florida, Tampa, USA, about the post hoc analysis. which concludes that prior administration of IV alteplase may adversely affect the efficacy of aspiration, whilst it does not seem to influence the stent retriever first approach to MT in patients with anterior circulation ELVO. Read the related paper on the JNIS website: https://jnis.bmj.com/content/early/2021/10/13/neurintsurg-2021-017943

Episode metadata supplied by the publisher feed · Published Nov 17, 2021

Embed this episode

NOW PLAYING

COMPASS: intravenous ateplase and the efficacy of aspiration vs. stent retriever thrombectomy

0:00 16:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JNIS Podcast?

This episode is 16 minutes long.

When was this JNIS Podcast episode published?

This episode was published on November 17, 2021.

Can I download this JNIS Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!